|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Slidgigtinstituttet |
|---|---|
| Collaborator: |
Pharma Nord |
| Information provided by: | Slidgigtinstituttet |
| ClinicalTrials.gov Identifier: | NCT00251069 |
Purpose
Glucosamine sulphate causes no changes in blood levels of cholesterol
| Condition | Intervention | Phase |
|---|---|---|
|
Osteoarthritis |
Drug: Glucosamine sulphate |
Phase IV |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
| Official Title: | Glucosamine Sulphate and Hypercholesterolaemia |
| Estimated Enrollment: | 66 |
| Study Start Date: | April 2005 |
| Estimated Study Completion Date: | August 2005 |
The effects on glucosamine sulphate on blood levels of choleterol is measuered in patients with mild to moderate osteoarthritis
Eligibility| Ages Eligible for Study: | 40 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria: Osteoarthritic pain, normal blood cholesterol levels -
Exclusion Criteria: Systemic diseases, pregnancy, need of medication besides painkillers
-
Contacts and Locations
More Information
| Study ID Numbers: | EudraCTnr 2005-000541-11 |
| Study First Received: | November 7, 2005 |
| Last Updated: | November 7, 2005 |
| ClinicalTrials.gov Identifier: | NCT00251069 History of Changes |
| Health Authority: | Denmark: Lægemiddelstyrelsen (Danish Health Authorities) |
|
glucosamine sulphate, osteoarthritis, cholesterol, |
|
Musculoskeletal Diseases Osteoarthritis Joint Diseases Arthritis Rheumatic Diseases |